Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures.

[1]  D. Licatalosi,et al.  FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism , 2011, Cell.

[2]  Kenny Q. Ye,et al.  De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.

[3]  Damian Smedley,et al.  The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data , 2014, Nucleic Acids Res..

[4]  R. Gibbs,et al.  Targeted enrichment beyond the consensus coding DNA sequence exome reveals exons with higher variant densities , 2011, Genome Biology.

[5]  Stephan J Sanders,et al.  A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.

[6]  M. Bucan,et al.  From Mouse to Human: Evolutionary Genomics Analysis of Human Orthologs of Essential Genes , 2013, PLoS genetics.

[7]  S Purcell,et al.  De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia , 2011, Molecular Psychiatry.

[8]  Epilepsy Phenome,et al.  De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.

[9]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.

[10]  K. Rauen,et al.  The RASopathies. , 2013, Annual review of genomics and human genetics.

[11]  Jean-Michel Claverie,et al.  The human gene damage index as a gene-level approach to prioritizing exome variants , 2015, Proceedings of the National Academy of Sciences.

[12]  L. Jan,et al.  Molecular basis for interactions of G protein betagamma subunits with effectors. , 1998, Science.

[13]  Magalie S Leduc,et al.  Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.

[14]  De novo mutations in epileptic encephalopathies , 2013 .

[15]  R. Doolittle,et al.  Repetitive segmental structure of the transducin beta subunit: homology with the CDC4 gene and identification of related mRNAs. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Shendure,et al.  De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes , 2012, Nature Genetics.

[17]  Yujun Han,et al.  Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios , 2015, Genetics in Medicine.

[18]  Stephan J Sanders,et al.  De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies , 2015, Science.

[19]  Michael R. Johnson,et al.  De novo mutations in the classic epileptic encephalopathies , 2013, Nature.

[20]  J. Rosenfeld,et al.  Refinement of causative genes in monosomy 1p36 through clinical and molecular cytogenetic characterization of small interstitial deletions , 2010, American journal of medical genetics. Part A.

[21]  S. Sprang,et al.  The structure of the G protein heterotrimer Giα1 β 1 γ 2 , 1995, Cell.

[22]  M. Daly,et al.  Interpreting de novo Variation in Human Disease Using denovolyzeR , 2015, Current protocols in human genetics.

[23]  E. Banks,et al.  De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.

[24]  B. Ebert,et al.  Mutations in G protein beta subunits promote transformation and kinase inhibitor resistance , 2014, Nature Medicine.

[25]  Kelly Schoch,et al.  Clinical application of exome sequencing in undiagnosed genetic conditions , 2012, Journal of Medical Genetics.

[26]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[27]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[28]  L. Jan,et al.  Molecular Basis for Interactions of G Protein βγ Subunits with Effectors , 1998 .

[29]  Judith A. Blake,et al.  The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and disease , 2014, Nucleic Acids Res..

[30]  H. Hamm,et al.  The 2.0 Å crystal structure of a heterotrimeric G protein , 1996, Nature.

[31]  Evan T. Geller,et al.  Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.

[32]  D. Goldstein,et al.  Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes , 2013, PLoS genetics.

[33]  S. Sprang,et al.  The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. , 1995, Cell.

[34]  K. Rauen,et al.  Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndrome , 2011, Clinical genetics.

[35]  Tomas W. Fitzgerald,et al.  Large-scale discovery of novel genetic causes of developmental disorders , 2014, Nature.